Search

Government agencies can use artificial intelligence to make better decisions and be more efficient while using Abt’s tools to mitigate risk.

One of the most exciting parts of my job is investigating the ways in which new tools and technologies can be used to improve peoples' lives. Blockchain and its related technologies are in a new camp—exciting, but its application’s aren’t yet obvious.

Check out our newest Corporate Newsletter!

The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies. 

Abt adapted annual nationwide flu surveys to respond to the novel SARS-CoV-2 pandemic and gather information on COVID-19 vaccination and vaccine hesitancy.

In this blog, Abt’s James White outlines what it might take to create resilient supply chains that can function unimpeded during crises such as COVID-19.

Matthew Eby has over 20 years of leadership experience in supporting life science research and consulting for military, federal public health, and international agencies. His diverse career spans basic and applied research on environmental bioremediation, designing nanomaterials to combat antimicrobial resistance, and protecting our nation against bioterrorism. He also led federal and international agencies in modernizing public health systems and pandemic response efforts. Clients have included the Air Force, Navy, Army, Defense Advanced Research Projects Agency, Centers for Disease Control and Prevention (CDC), Food and Drug Administration, National Institutes of Health, and United Arab Emirates. He  has authored more than 20 peer-reviewed publications with 1000+ citations. He also is an active supporter of local community initiatives that tackle affordable housing, food insecurity, and systemic poverty.